Log In
BCIQ
Print this Print this
 

VAY736

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionHuman HuCAL antibody against BAFF-R
Molecular Target BLyS (BAFF) receptors
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today